Molecules 2009, 14(10), 3869-3880; doi:10.3390/molecules14103869
Review

A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol

Chugai Pharmaceutical Co., Ltd., 2-1-1, Nihonbashi-Muromachi, Chuo-ku, Tokyo 103-8324, Japan
Received: 10 September 2009; in revised form: 28 September 2009 / Accepted: 28 September 2009 / Published: 29 September 2009
(This article belongs to the Special Issue Prodrugs)
PDF Full-text Download PDF Full-Text [89 KB, uploaded 29 September 2009 08:32 CEST]
Abstract: Alfacalcidol (1α-hydroxyvitamin D3) has been widely used since 1981 as a prodrug for calcitriol (1α,25-dihydroxyvitamin D3) in the treatment of hypocalcemia, chronic renal failure, hypoparathyroidism and osteoporosis. More recently, doxercalciferol (1α-hydroxyvitamin D2) has been used since 1999 as a prodrug for 1α,25-dihydroxyvitamin D2 for the treatment of secondary hyperparathyroidism. Currently, six forms of vitamin D are known. They range from vitamin D2 to vitamin D7 and are distinguished by their differing side chains. Only vitamin D2 and vitamin D3 have been found to be biologically active based on the elucidation of activation pathways. Alfacalcidol and osteoporosis/doxercalciferol and secondary hyperparathyroidism are discussed, with a new look at old compounds including their practical syntheses.
Keywords: prodrugs; vitamin D; D hormone; alfacalcidol; doxercalciferol; practical syntheses

Article Statistics

Load and display the download statistics.

Citations to this Article

Cite This Article

MDPI and ACS Style

Kubodera, N. A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol. Molecules 2009, 14, 3869-3880.

AMA Style

Kubodera N. A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol. Molecules. 2009; 14(10):3869-3880.

Chicago/Turabian Style

Kubodera, Noboru. 2009. "A New Look at the Most Successful Prodrugs for Active Vitamin D (D Hormone): Alfacalcidol and Doxercalciferol." Molecules 14, no. 10: 3869-3880.

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert